Home > Online Clinic News > Saxenda (Liraglutide) Given Green Light

Latest News

by Robert MacKay, Saturday, January 24, 2015 | Categories: Weight Loss

The Committee for Medicinal Products for Human Use of the European Medicines Agency has recommended Saxenda (Liraglutide) for approval throughout the EU for the treatment of obese and overweight patients.

Saxenda works by activating the GLP-1 receptors in the body and causing us to feel full. Saxenda works as an appetite suppressant and it has proven enormously successful in clinical trials. Many patients have lost significant weight and blood pressure has been brought back under control.

The Online Clinic has been prescribing Liraglutide off-label for a few years as the clinical evidence of weight loss is significant and the side effects are limited. Liraglutide appears to be a very safe medication and the side effects that are common in the beginning (such as nausea) usually disappear with continued use. Using a low dose of the medication for a couple of weeks normally eliminates any incidence of side effects.

The company behind Saxenda will apply for this medication to be prescribed on the NHS but this may not be recommended for approval because of the cost.

Liraglutide is available through The Online Clinic for next day delivery so long as you meet our prescribing criteria. You can register by clicking on the button below.

Free Online Assessment

Quick and Without Obligation

We use cookies on this website. By using this site, you agree that we may store and access cookies on your device. Find out more Close